DaVita HealthCare Partners Inc. (NYSE:DVA) was down 0.6% during mid-day trading on Tuesday . The stock traded as low as $53.86 and last traded at $54.20. Approximately 3,310,992 shares changed hands during trading, an increase of 100% from the average daily volume of 1,652,790 shares. The stock had previously closed at $53.89.
Several equities research analysts recently issued reports on DVA shares. TheStreet lowered DaVita HealthCare Partners from a “b” rating to a “c+” rating in a research report on Wednesday, August 2nd. Jefferies Group LLC lowered DaVita HealthCare Partners from a “buy” rating to a “hold” rating and upped their price target for the company from $64.89 to $70.00 in a research report on Monday, June 26th. Royal Bank Of Canada reissued a “hold” rating and set a $64.00 price target on shares of DaVita HealthCare Partners in a research report on Wednesday, September 6th. Zacks Investment Research raised DaVita HealthCare Partners from a “sell” rating to a “hold” rating in a research report on Thursday, August 3rd. Finally, BidaskClub lowered DaVita HealthCare Partners from a “hold” rating to a “sell” rating in a research report on Saturday, July 8th. Three investment analysts have rated the stock with a sell rating, six have assigned a hold rating and one has assigned a buy rating to the stock. The stock currently has an average rating of “Hold” and a consensus price target of $66.50.
The company has a market capitalization of $10.39 billion, a PE ratio of 8.27 and a beta of 0.90. The company has a 50-day moving average price of $58.53 and a 200 day moving average price of $63.22.
DaVita HealthCare Partners (NYSE:DVA) last issued its quarterly earnings data on Tuesday, August 1st. The company reported $0.92 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $0.90 by $0.02. DaVita HealthCare Partners had a return on equity of 14.02% and a net margin of 8.68%. The firm had revenue of $3.88 billion during the quarter, compared to the consensus estimate of $3.82 billion. During the same quarter in the previous year, the company posted $1.01 EPS. The business’s revenue for the quarter was up 4.3% compared to the same quarter last year. Analysts anticipate that DaVita HealthCare Partners Inc. will post $3.59 earnings per share for the current year.
A number of institutional investors and hedge funds have recently modified their holdings of DVA. Pzena Investment Management LLC raised its position in DaVita HealthCare Partners by 2.1% in the 2nd quarter. Pzena Investment Management LLC now owns 3,398 shares of the company’s stock valued at $220,000 after purchasing an additional 71 shares during the last quarter. Pacer Advisors Inc. raised its position in DaVita HealthCare Partners by 3.0% in the 1st quarter. Pacer Advisors Inc. now owns 3,422 shares of the company’s stock valued at $233,000 after purchasing an additional 101 shares during the last quarter. Kovitz Investment Group Partners LLC bought a new position in DaVita HealthCare Partners in the 1st quarter valued at $289,000. Eqis Capital Management Inc. raised its position in DaVita HealthCare Partners by 2.2% in the 2nd quarter. Eqis Capital Management Inc. now owns 4,600 shares of the company’s stock valued at $298,000 after purchasing an additional 100 shares during the last quarter. Finally, First Financial Equity Corporation bought a new position in DaVita HealthCare Partners in the 1st quarter valued at $304,000. Hedge funds and other institutional investors own 83.27% of the company’s stock.
About DaVita HealthCare Partners
DaVita Inc, formerly DaVita HealthCare Partners Inc, operates two divisions: DaVita Kidney Care (Kidney Care) and DaVita Medical Group (DMG). The Kidney Care division consists of its the United States dialysis and related lab services, its ancillary services and strategic initiatives, including its international operations, and its corporate administrative support.
Receive News & Ratings for DaVita HealthCare Partners Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DaVita HealthCare Partners Inc. and related companies with MarketBeat.com's FREE daily email newsletter.